168 related articles for article (PubMed ID: 37824291)
1. Altering the Cleaving Effector in Chimeric Molecules that Target RNA Enhances Cellular Selectivity.
Suresh BM; Tong Y; Abegg D; Adibekian A; Childs-Disney JL; Disney MD
ACS Chem Biol; 2023 Nov; 18(11):2385-2393. PubMed ID: 37824291
[TBL] [Abstract][Full Text] [Related]
2. Methods for the study of ribonuclease targeting chimeras (RiboTACs).
Springer NA; Meyer SM; Taghavi A; Benhamou RI; Tong Y; Childs-Disney JL; Disney MD
Methods Enzymol; 2023; 692():249-298. PubMed ID: 37925183
[TBL] [Abstract][Full Text] [Related]
3. DNA-Encoded Library Screening To Inform Design of a Ribonuclease Targeting Chimera (RiboTAC).
Meyer SM; Tanaka T; Zanon PRA; Baisden JT; Abegg D; Yang X; Akahori Y; Alshakarchi Z; Cameron MD; Adibekian A; Disney MD
J Am Chem Soc; 2022 Nov; 144(46):21096-21102. PubMed ID: 36342850
[TBL] [Abstract][Full Text] [Related]
4. How We Think about Targeting RNA with Small Molecules.
Costales MG; Childs-Disney JL; Haniff HS; Disney MD
J Med Chem; 2020 Sep; 63(17):8880-8900. PubMed ID: 32212706
[TBL] [Abstract][Full Text] [Related]
5. Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype.
Li Y; Disney MD
ACS Chem Biol; 2018 Nov; 13(11):3065-3071. PubMed ID: 30375843
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin Can Cleave an Oncogenic Noncoding RNA.
Angelbello AJ; Disney MD
Chembiochem; 2018 Jan; 19(1):43-47. PubMed ID: 29084369
[TBL] [Abstract][Full Text] [Related]
7. Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.
Liu X; Haniff HS; Childs-Disney JL; Shuster A; Aikawa H; Adibekian A; Disney MD
J Am Chem Soc; 2020 Apr; 142(15):6970-6982. PubMed ID: 32233464
[TBL] [Abstract][Full Text] [Related]
8. Programming inactive RNA-binding small molecules into bioactive degraders.
Tong Y; Lee Y; Liu X; Childs-Disney JL; Suresh BM; Benhamou RI; Yang C; Li W; Costales MG; Haniff HS; Sievers S; Abegg D; Wegner T; Paulisch TO; Lekah E; Grefe M; Crynen G; Van Meter M; Wang T; Gibaut QMR; Cleveland JL; Adibekian A; Glorius F; Waldmann H; Disney MD
Nature; 2023 Jun; 618(7963):169-179. PubMed ID: 37225982
[TBL] [Abstract][Full Text] [Related]
9. Targeted Degradation of Structured RNAs via Ribonuclease-Targeting Chimeras (RiboTacs).
Haj-Yahia S; Nandi A; Benhamou RI
Expert Opin Drug Discov; 2023; 18(8):929-942. PubMed ID: 37306675
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.
Costales MG; Aikawa H; Li Y; Childs-Disney JL; Abegg D; Hoch DG; Pradeep Velagapudi S; Nakai Y; Khan T; Wang KW; Yildirim I; Adibekian A; Wang ET; Disney MD
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2406-2411. PubMed ID: 31964809
[TBL] [Abstract][Full Text] [Related]
11.
Tong Y; Gibaut QMR; Rouse W; Childs-Disney JL; Suresh BM; Abegg D; Choudhary S; Akahori Y; Adibekian A; Moss WN; Disney MD
J Am Chem Soc; 2022 Jul; 144(26):11620-11625. PubMed ID: 35737519
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-RIBOTAC Strategy Enabling Tumor-Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy.
Fang Y; Wu Q; Wang F; Liu Y; Zhang H; Yang C; Zhu Z
Small Methods; 2024 May; ():e2400349. PubMed ID: 38794853
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment.
Zhang P; Liu X; Abegg D; Tanaka T; Tong Y; Benhamou RI; Baisden J; Crynen G; Meyer SM; Cameron MD; Chatterjee AK; Adibekian A; Childs-Disney JL; Disney MD
J Am Chem Soc; 2021 Aug; 143(33):13044-13055. PubMed ID: 34387474
[TBL] [Abstract][Full Text] [Related]
14. Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.
Costales MG; Suresh B; Vishnu K; Disney MD
Cell Chem Biol; 2019 Aug; 26(8):1180-1186.e5. PubMed ID: 31130520
[TBL] [Abstract][Full Text] [Related]
15. The bacterial endoribonuclease RNase E can cleave RNA in the absence of the RNA chaperone Hfq.
Baek YM; Jang KJ; Lee H; Yoon S; Baek A; Lee K; Kim DE
J Biol Chem; 2019 Nov; 294(44):16465-16478. PubMed ID: 31540970
[TBL] [Abstract][Full Text] [Related]
16. Small molecule recognition of disease-relevant RNA structures.
Meyer SM; Williams CC; Akahori Y; Tanaka T; Aikawa H; Tong Y; Childs-Disney JL; Disney MD
Chem Soc Rev; 2020 Oct; 49(19):7167-7199. PubMed ID: 32975549
[TBL] [Abstract][Full Text] [Related]
17. RNA-binding protein HuR and the members of the miR-200 family play an unconventional role in the regulation of c-Jun mRNA.
Del Vecchio G; De Vito F; Saunders SJ; Risi A; Mannironi C; Bozzoni I; Presutti C
RNA; 2016 Oct; 22(10):1510-21. PubMed ID: 27473170
[TBL] [Abstract][Full Text] [Related]
18. Small Molecule Targeted Recruitment of a Nuclease to RNA.
Costales MG; Matsumoto Y; Velagapudi SP; Disney MD
J Am Chem Soc; 2018 Jun; 140(22):6741-6744. PubMed ID: 29792692
[TBL] [Abstract][Full Text] [Related]
19. Development of a ribonuclease containing a G4-specific binding motif for programmable RNA cleavage.
Dang DT; Phan AT
Sci Rep; 2019 May; 9(1):7432. PubMed ID: 31092834
[TBL] [Abstract][Full Text] [Related]
20. Ribonuclease P substrate specificity: cleavage of a bacteriophage phi80-induced RNA.
Bothwell AL; Stark BC; Altman S
Proc Natl Acad Sci U S A; 1976 Jun; 73(6):1912-6. PubMed ID: 778851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
